(NGEN) NervGen Pharma - Performance 47.5% in 12m
Compare NGEN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
48.94%
#10 in Group
Rel. Strength
90.29%
#778 in Universe
Total Return 12m
47.52%
#23 in Group
Total Return 5y
105.52%
#19 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -5.83%
(?) Percentile in Group
12m Total Return: NGEN (47.5%) vs XBI (-12.1%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
| LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: NGEN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NGEN
| Total Return (including Dividends) | NGEN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.36% | -14.90% | -7.04% |
| 3 Months | 1.02% | -14.51% | -10.88% |
| 12 Months | 47.52% | -12.11% | 5.72% |
| 5 Years | 105.52% | -20.56% | 100.77% |
| Trend Score (consistency of price movement) | NGEN | XBI | S&P 500 |
| 1 Month | 62.4% | -85.2% | -76.1% |
| 3 Months | -22.3% | -87.6% | -86.4% |
| 12 Months | 52.0% | -24% | 67.8% |
| 5 Years | 45.5% | -52.8% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #21 | 27.3% | 16.6% |
| 3 Month | #29 | 18.2% | 13.4% |
| 12 Month | #22 | 67.9% | 39.5% |
| 5 Years | #20 | 159% | 2.36% |
FAQs
Does NGEN NervGen Pharma outperforms the market?
Yes,
over the last 12 months NGEN made 47.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months NGEN made 1.02%, while XBI made -14.51%.
Over the last 3 months NGEN made 1.02%, while XBI made -14.51%.
Performance Comparison NGEN vs Indeces and Sectors
NGEN vs. Indices NGEN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.02% | 15.4% | 30.8% | 41.8% |
| US NASDAQ 100 | QQQ | 8.51% | 16.2% | 30.9% | 43.9% |
| US Dow Jones Industrial 30 | DIA | 6.12% | 13.5% | 28.8% | 40.8% |
| German DAX 40 | DAX | -4.48% | 16.4% | 12.2% | 28.2% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.02% | 16.1% | 25.9% | 39.6% |
| Hongkong Hang Seng | HSI | 0.35% | 19.5% | 29.4% | 31.4% |
| India NIFTY 50 | INDA | 4.01% | 4.94% | 31.4% | 46.8% |
| Brasil Bovespa | EWZ | 3.51% | 14.6% | 30.5% | 58.5% |
NGEN vs. Sectors NGEN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8.21% | 15.9% | 22.6% | 34.3% |
| Consumer Discretionary | XLY | 9.61% | 14.6% | 28.6% | 40.2% |
| Consumer Staples | XLP | 2.76% | 8.47% | 23.1% | 35.0% |
| Energy | XLE | 7.06% | 20.3% | 31.8% | 60.3% |
| Financial | XLF | 5.31% | 13.2% | 22.9% | 28.2% |
| Health Care | XLV | 5.61% | 15.1% | 32.0% | 47.7% |
| Industrial | XLI | 5.52% | 14.3% | 31.4% | 43.6% |
| Materials | XLB | 4.52% | 15.8% | 38.2% | 55.5% |
| Real Estate | XLRE | 2.27% | 13.4% | 31.1% | 33.2% |
| Technology | XLK | 8.71% | 18.2% | 36.8% | 50.7% |
| Utilities | XLU | 2.50% | 10.5% | 26.6% | 21.1% |
| Aerospace & Defense | XAR | 3.36% | 8.97% | 21.4% | 24.4% |
| Biotech | XBI | 3.50% | 23.3% | 46.7% | 59.6% |
| Homebuilder | XHB | 8.63% | 17.6% | 50.2% | 59.2% |
| Retail | XRT | 8.26% | 14.1% | 38.1% | 54.5% |